Literature DB >> 23725016

E-cadherin autoantibody profile in patients with pemphigus vulgaris.

M E F Oliveira1, D A Culton, P Prisayanh, B F Qaqish, L A Diaz.   

Abstract

BACKGROUND: Pemphigus vulgaris (PV) is an autoimmune skin blistering disease. The main targets of autoantibodies are the desmosomal proteins desmoglein (Dsg)3 and Dsg1. Anti-E-cadherin antibody is the second most frequent antibody found in pemphigus foliaceus (fogo selvagem), but the frequency in PV is unknown.
OBJECTIVES: To determine the anti-E-cadherin antibody profile in the two major subtypes of PV: mucosal PV (mPV) and mucocutaneous PV (mcPV).
METHODS: Sera from 80 patients with PV and 80 controls were tested. Patients with PV were subdivided into mPV (n = 18) and mcPV (n = 62). Samples were tested by E-cadherin, Dsg1 and Dsg3 enzyme-linked immunosorbent assays (ELISAs), and immunoprecipitation coupled with Western blotting (IP-WB).
RESULTS: Both mPV and mcPV sera have antibodies against E-cadherin as demonstrated by ELISA and IP-WB. Both subtypes of PV have low levels of anti-E-cadherin antibodies, but significantly higher levels than healthy controls by ELISA (P < 0·0001). No difference exists in antibody levels between subgroups (P = 0·82). By IP-WB, 78% of mcPV sera reacted to E-cadherin, vs. 33% of mPV sera tested. Correlation analysis suggests a moderate correlation between anti-E-cadherin antibodies and Dsg1 antibodies (average r = 0·61), but no correlation with Dsg3 antibodies (average r = 0·19). Patients with mPV can have lower levels of Dsg1 antibodies compared with controls by ELISA (P < 0·0001). A few mPV sera also reacted to Dsg1 protein by IP-WB (17%).
CONCLUSIONS: Anti-E-cadherin antibodies are present in both major subtypes of PV. A moderate correlation exists between E-cadherin and Dsg1 antibodies. Patients with mPV can have low levels of both E-cadherin and Dsg1 antibodies.
© 2013 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23725016     DOI: 10.1111/bjd.12455

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  9 in total

Review 1.  Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.

Authors:  Robert Pollmann; Thomas Schmidt; Rüdiger Eming; Michael Hertl
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

2.  E-cadherin and Src associate with extradesmosomal Dsg3 and modulate desmosome assembly and adhesion.

Authors:  Vera Rötzer; Eva Hartlieb; Franziska Vielmuth; Martin Gliem; Volker Spindler; Jens Waschke
Journal:  Cell Mol Life Sci       Date:  2015-06-27       Impact factor: 9.261

Review 3.  Immune response in pemphigus and beyond: progresses and emerging concepts.

Authors:  Giovanni Di Zenzo; Kyle T Amber; Beyza S Sayar; Eliane J Müller; Luca Borradori
Journal:  Semin Immunopathol       Date:  2015-11-23       Impact factor: 9.623

4.  Detection of apoptosis in pemphigus vulgaris by TUNEL technique.

Authors:  Juan Carlos Cuevas-Gonzalez; Maria Elisa Vega-Memíje; Francisco Javier García-Vázquez; Marco António Aguilar-Urbano
Journal:  An Bras Dermatol       Date:  2016 May-Jun       Impact factor: 1.896

5.  Pathophysiology of Autoimmune Bullous Diseases: Nature Versus Nurture.

Authors:  Forum Patel; Reason Wilken; Falin B Patel; Hawa Sultani; Itzel Bustos; Christopher Duong; John J Zone; Siba P Raychaudhuri; Emanual Maverakis
Journal:  Indian J Dermatol       Date:  2017 May-Jun       Impact factor: 1.494

Review 6.  Non-Desmoglein Antibodies in Patients With Pemphigus Vulgaris.

Authors:  Kyle T Amber; Manuel Valdebran; Sergei A Grando
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

Review 7.  Autoimmune Pemphigus: Latest Advances and Emerging Therapies.

Authors:  Yen Loo Lim; Gerome Bohelay; Sho Hanakawa; Philippe Musette; Baptiste Janela
Journal:  Front Mol Biosci       Date:  2022-02-04

8.  Desmogleins 1, 3, and E-cadherin immunohistochemical expression within mucocutaneous pemphigus vulgaris.

Authors:  Muhanad Lebnan Alshami; Fawaz Aswad; Bashar Abdullah
Journal:  Pan Afr Med J       Date:  2022-07-07

Review 9.  Evolving Mechanisms in the Pathophysiology of Pemphigus Vulgaris: A Review Emphasizing the Role of Desmoglein 3 in Regulating p53 and the Yes-Associated Protein.

Authors:  Ambreen Rehman; Yunying Huang; Hong Wan
Journal:  Life (Basel)       Date:  2021-06-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.